HF Patients With LVADs Being Treated With SGLT2i
Phase 4
Recruiting
- Conditions
- Heart Failure With Reduced Ejection Fraction
- Registration Number
- NCT05278962
- Lead Sponsor
- University of Chicago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Inclusion Criteria:<br><br> 1. LVAD implantation<br><br> 2. Have not already been prescribed management with an SGLT2i<br><br> 3. Estimated glomerular filtration rate (eGFR) = 30 milliliters(ml)/minute(min)/1.73<br> meter(m)2<br><br> 4. Age = 18 years-old<br><br> 5. Able to provide informed consent<br><br>Exclusion Criteria:<br><br> 1. Diagnosis of Type 1 diabetes mellitus<br><br> 2. eGFR < 30 ml/min/1.73 m2<br><br> 3. Age < 18 years-old
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in number of ramp stages needed to achieve hemodynamic optimization
- Secondary Outcome Measures
Name Time Method